Stemline Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 7 U.S.-traded ETFs. STML has around 454.4K shares in the U.S. ETF market. The largest ETF holder of STML is the Vanguard Total Stock Market ETF (VTI), with approximately 205.52K shares. Investors may also find of interest that the ETF with the largest allocation to STML stock is Vanguard Russell 2000 Growth ETF (VTWG), with a portfolio weight of 0.05%. On average, U.S. ETFs allocate 0.02% of STML to their portfolios.